IMUX
Price
$1.25
Change
-$0.04 (-3.10%)
Updated
May 16, 6:59 PM EST
77 days until earnings call
ROIV
Price
$11.41
Change
-$0.09 (-0.78%)
Updated
May 16, 6:59 PM EST
40 days until earnings call
Ad is loading...

IMUX vs ROIV

Header iconIMUX vs ROIV Comparison
Open Charts IMUX vs ROIVBanner chart's image
Immunic
Price$1.25
Change-$0.04 (-3.10%)
Volume$162.41K
CapitalizationN/A
Roivant Sciences
Price$11.41
Change-$0.09 (-0.78%)
Volume$2.02M
CapitalizationN/A
View a ticker or compare two or three
IMUX vs ROIV Comparison Chart

Loading...

IMUXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ROIVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IMUX vs. ROIV commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and ROIV is a Hold.

COMPARISON
Comparison
May 17, 2024
Stock price -- (IMUX: $1.29 vs. ROIV: $11.50)
Brand notoriety: IMUX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 45% vs. ROIV: 40%
Market capitalization -- IMUX: $112.6M vs. ROIV: $9.19B
IMUX [@Biotechnology] is valued at $112.6M. ROIV’s [@Biotechnology] market capitalization is $9.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $592.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • IMUX’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMUX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 2 TA indicator(s) are bullish while ROIV’s TA Score has 6 bullish TA indicator(s).

  • IMUX’s TA Score: 2 bullish, 6 bearish.
  • ROIV’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а +1.97% price change this week, while ROIV (@Biotechnology) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +4.69%, and the average quarterly price growth was +62.76%.

Reported Earning Dates

IMUX is expected to report earnings on Aug 01, 2024.

ROIV is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IMUX with price predictions.
OPEN
A.I.dvisor published
a Summary for ROIV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ROIV($9.2B) has a higher market cap than IMUX($113M). ROIV YTD gains are higher at: 2.404 vs. IMUX (-13.667).
IMUXROIVIMUX / ROIV
Capitalization113M9.2B1%
EBITDAN/AN/A-
Gain YTD-13.6672.404-568%
P/E RatioN/A2.17-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXROIV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
IMUXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ROIVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TGRW34.880.52
+1.51%
T. Rowe Price Growth Stock ETF
DIA399.283.70
+0.94%
SPDR® Dow Jones Industrial Avrg ETF Tr
IVOV90.830.32
+0.35%
Vanguard S&P Mid-Cap 400 Value ETF
INMU23.710.07
+0.29%
BlackRock Intermediate Muni Inc Bd ETF
VSDA49.690.12
+0.25%
VictoryShares Dividend Accelerator ETF

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with DNA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
+1.17%
DNA - IMUX
38%
Loosely correlated
-2.75%
FOLD - IMUX
36%
Loosely correlated
+3.54%
NTLA - IMUX
34%
Loosely correlated
+1.90%
CDXS - IMUX
34%
Loosely correlated
+1.37%
CTMX - IMUX
32%
Poorly correlated
+1.03%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.50%
IMVT - ROIV
61%
Loosely correlated
+1.48%
IONS - ROIV
43%
Loosely correlated
+2.46%
AXON - ROIV
43%
Loosely correlated
-0.85%
FOLD - ROIV
41%
Loosely correlated
+3.54%
SLNO - ROIV
40%
Loosely correlated
+3.93%
More